- Stocks
- Healthcare
- NYSE: TMO

Price (delayed)

$518.22

Market cap

$205.39B

P/E Ratio

42.13

Dividend/share

$0.88

EPS

$12.3

Enterprise value

$218.94B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry .

Thermo Fisher Scientific's quick ratio has soared by 110% YoY and by 19% from the previous quarter

TMO's EPS is up by 37% year-on-year and by 32% since the previous quarter

The stock's price to earnings (P/E) is 30% more than its 5-year quarterly average of 32.5 and 23% more than its last 4 quarters average of 34.3

The debt has increased by 24% YoY

What are the main financial stats of TMO

Market
Valuations
Earnings

Shares outstanding

396.34M

Market cap

$205.39B

Enterprise value

$218.94B

Price to earnings (P/E)

42.13

Price to book (P/B)

6.44

Price to sales (P/S)

7.2

EV/EBIT

33.92

EV/EBITDA

25.01

EV/Sales

7.68

Revenue

$28.5B

EBIT

$6.45B

EBITDA

$8.75B

Free cash flow

$5.71B

Per share
Balance sheet
Liquidity

EPS

$12.3

Free cash flow per share

$14.42

Book value per share

$80.45

Revenue per share

$71.96

TBVPS

$64.16

Total assets

$64.06B

Total liabilities

$32.24B

Debt

$21.09B

Equity

$31.82B

Working capital

$12.01B

Debt to equity

0.66

Current ratio

2.93

Quick ratio

2.04

Net debt/EBITDA

1.55

Margins
Efficiency
Dividend

EBITDA margin

30.7%

Gross margin

47.3%

Net margin

17.1%

Operating margin

20.9%

Return on assets

8%

Return on equity

16.3%

Return on invested capital

20.9%

Return on capital employed

11.2%

Return on sales

22.6%

Dividend yield

0.17%

DPS

$0.88

Payout ratio

7.2%

How has the Thermo Fisher Scientific stock price performed over time

Intraday

0.46%

1 week

4.29%

1 month

11.96%

1 year

53.66%

YTD

11.26%

QTD

11.26%

How have Thermo Fisher Scientific's revenue and profit performed over time

Revenue

$28.5B

Gross profit

$13.48B

Operating income

$5.96B

Net income

$4.88B

Gross margin

47.3%

Net margin

17.1%

Thermo Fisher Scientific's net income has increased by 36% YoY and by 32% from the previous quarter

The operating income has grown by 33% from the previous quarter and by 32% YoY

Thermo Fisher Scientific's operating margin has increased by 23% from the previous quarter and by 17% YoY

The net margin has increased by 21% QoQ and by 20% YoY

What is Thermo Fisher Scientific's growth rate over time

What is Thermo Fisher Scientific stock price valuation

P/E

42.13

P/B

6.44

P/S

7.2

EV/EBIT

33.92

EV/EBITDA

25.01

EV/Sales

7.68

TMO's EPS is up by 37% year-on-year and by 32% since the previous quarter

The stock's price to earnings (P/E) is 30% more than its 5-year quarterly average of 32.5 and 23% more than its last 4 quarters average of 34.3

The P/B is 84% above the 5-year quarterly average of 3.5 and 43% above the last 4 quarters average of 4.5

The company's equity rose by 8% YoY and by 7% QoQ

The P/S is 80% above the 5-year quarterly average of 4.0 and 41% above the last 4 quarters average of 5.1

Thermo Fisher Scientific's revenue has increased by 13% YoY and by 9% from the previous quarter

How efficient is Thermo Fisher Scientific business performance

The ROE has grown by 29% from the previous quarter and by 28% YoY

TMO's ROA is up by 27% from the previous quarter and by 27% YoY

TMO's return on invested capital is up by 22% since the previous quarter and by 7% year-on-year

TMO's ROS is up by 18% since the previous quarter and by 9% year-on-year

What is TMO's dividend history

DPS

$0.88

Dividend yield

0.17%

Payout ratio

7.2%

Recent dividends

How did Thermo Fisher Scientific financials performed over time

The total assets is 99% greater than the total liabilities

Thermo Fisher Scientific's quick ratio has soared by 110% YoY and by 19% from the previous quarter

The current ratio has surged by 63% year-on-year and by 12% since the previous quarter

The debt is 34% lower than the equity

Thermo Fisher Scientific's debt to equity has increased by 14% YoY but it has decreased by 7% QoQ

The company's equity rose by 8% YoY and by 7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.